Zydus Cadila | Zee News

Advertisement

NewsZydus Cadila

Zydus Cadila News

31 Dec 2023

Pankaj Patel's Journey: From Cadila Laboratories To Owner Of Rs...

Raised in a traditional Patel family, Patel studied at Sheth C. N. Vidyalaya and later earned a Master of Pharmacy degree from L M Pharmacy, Ahmedabad.

05 Feb 2022

All about ZyCov D, India's first needleless vaccine launched in Bihar's Patna

ZyCov D is the world's first DNA vaccine It was approved by DSCO in August 2021

02 Dec 2021

Zydus Cadila's ZyCoV-D to be initially introduced in THESE seven states

ZyCoV-D will likley to be administered to only adults initially. Centre placed an order of one crore doses of ZyCoV-D earlier.

07 Nov 2021

Centre places order for one crore doses of Zydus Cadila's COVID vaccine

ZyCoV-D is likely to be rolled out in November. ZyCoV-D vaccine is world's first DNA-based COVID-19 jab. ZyCoV-D received emergency use authorisation on August 20.

31 Oct 2021

Zydus Cadila to reduce COVID vaccine price to Rs 265, final decision soon

Zydus Cadila's COVID-19 vaccine is the first vaccine to be approved by India's drug regulator for inoculation to 12 years and over.

Biological E Corbevax vaccine

03 Sep 2021

Biological E gets nod for phase 2/3 clinical trial for vaccine on children

Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents Corbevax, an RBD protein sub-unit vaccine, has been developed with supported from the Department of Biotechnology.

24 Aug 2021

Priority vaccination for children above 12 with comorbidities: Govt panel

NTAGI chief has said that comorbid kids will be given the COVID-19 vaccine first NK Arora added that vaccinating adults will remain the top priority for the govt agencies DCGI had last week granted its approval to Zydus Cadila’s three-dose COVID-19 DNA vaccine for emergency use in adults and children

22 Aug 2021

Zydus Cadila hopes to begin supply of ZyCoV-D vaccine by mid to end September

Zydus Group is hoping to begin the supply of the ZyCoV-D COVID-19 vaccine by mid to end September. Zydus Cadila's indigenously developed needle-free three-dose vaccine was granted EUA on Friday. It became the first vaccine to be administered to beneficiaries in the age group of 12-18 years in the country.

22 Aug 2021

ZyCoV-D - needle-free COVID vaccine for adults and kids - all you need to know

Zydus Cadila in July had said that ZyCoV-D was effective against the new mutants of COVID-19, especially the Delta variant.

20 Aug 2021

Zydus Cadila's COVID vaccine ZyCoV-D, first jab for kids in India, gets nod

Zydus Cadila Covid vaccine ZyCoV-D is India's first COVID-19 vaccine for children to receive approval. ZyCoV-D, a three-dose vaccine, is world's first DNA-based vaccine against the coronavirus. ZyCoV-D, is a needle-free vaccine administered using a needle free applicator.

09 Aug 2021

Zydus Cadila likely to get emergency use approval for its COVID vaccine soon

Zydus Cadila may get emergency use approval for its COVID vaccine this week The firm said last month that it has applied for EUA for its three-dose COVID-19 vaccine ZyCoV-D It plans to manufacture 10-12 crore doses annually

01 Jul 2021

Zydus Cadila seeks DCGI's permission for emergency use of its COVID-19 vaccine for those above 12

Gujarat-based pharmaceutical company Zydus Cadila has completed the Phase III trial of its coronavirus vaccine. Following which, the company has sought approval from the Drugs Controller General of India (DCGI) for emergency use of this drug on people above 12 years of age.

01 Jul 2021

Zydus Cadila seeks emergency use approval for COVID vaccine for 12 years old

Zydus Cadila is seeking emergency use approval for the COVID vaccine for 12 years old and above The vaccine has completed the third phase of the trial, it added

27 Jun 2021

COVID-19 vaccine Zydus Cadila for children above 12 expected by August, NTAGI

The NTAGI chief also said that vaccination-related rumours are vague and vaccines in India are 95-96 per cent safe We have a window period of 6-8 months to immunise everybody in the country, he added Zydus Cadila COVID-19 vaccine for children above 12 years is expected to be available by August

24 Apr 2021

Can 'Virafin' be a viable alternative for Remdesivir as COVID-19 wreaks havoc?

The nod from DGCI comes at a time when India is combating the second wave of COVID-19 Virafin is a single dose anti-viral drug The drug ensures faster viral clearance

23 Apr 2021

DNA: Virafin, a hope to eradicate COVID-19

Zydus Cadila on Friday received approval from the Drug Controller General of India (DGCI) for emergency use of the drug Virafin. Antiviral Virafin will reportedly make treatment more convenient for COVID-19 patients.

23 Apr 2021

Emergency use of Zydus Cadila's drug Virafin approved against COVID-19

To speed up the treatment of Coronavirus patients, the Drug Controller General of India (DGCI) on Friday approved the emergency use of Zydus Cadila's drug Virafin. This medicine can be used to treat patients above 18 years of age.

23 Apr 2021

Zydus Cadila gets emergency use nod for 'Virafin' to treat moderate COVID-19

DGCI approves Zydus Cadila's drug Virafin gets official nod for treating moderate COVID-19 infection in adults

01 Jan 2021

We will have an amazing New Year Today, After Vaccination approval?

The approval for a Covid vaccine can come soon, the country's drugs control authority has indicated.

06 Dec 2020

Corona Vaccine : Pfizer Seeks India Approval For Covid Vaccine

Pfizer has sought approval from the country's drug regulator - the DCGI (Drugs Controller General of India) - for emergency use authorization of its coronavirus vaccine.

Loading...

NEWS ON ONE CLICK